Definition
MDMA and other altered-state treatments may increase suggestibility — the readiness to accept ideas, interpretations, or narratives from a trusted other. This creates real risk of implanted content and boundary violation.
Why it matters
Increased openness combined with increased suggestibility places significant ethical demands on the clinician. Naming this openly protects patients.
The Science
Suggestibility has been documented across altered states. Formal research specific to MDMA-assisted therapy is ongoing.
The NSI Perspective
Trust is a resource that must be protected in both directions. NSI treats consent as ongoing, revisable, and central to safety.
Clinical Implications
Protocols should include audio/video documentation, second-clinician presence, and explicit prohibition of interpretation during peak effects.
Practical Application
Read consent forms carefully. Ask what protects you against interpretations that may not be yours.
References
- 1.Yaden DB, et al. Ethical considerations for psychedelic-assisted therapy. Neuropharmacology. 2022;219:109194.